Arrowhead Pharmaceuticals, Inc. (ARWR)
64.50
-1.75
(-2.64%)
USD |
NASDAQ |
Jan 16, 15:08
Arrowhead Pharmaceuticals SG&A Expense (TTM): 123.94M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 527.29M |
| Eli Lilly & Co. | 10.39B |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| Cidara Therapeutics, Inc. | 28.09M |
| Celcuity, Inc. | 18.59M |